Slc1a1 marker for anxiety disorder

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 38/17 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2528222

The present invention provides methods for diagnosing or identifying susceptibility of a subject to an anxiety or mood disorder. One method involves testing a sample obtained from the subject for the presence of a polymorphism in Intron 10 of the SLC1A1 gene. The presence of allele G or allele A of the A/G polymorphism rs301434 indicates that the patient is susceptible to an anxiety disorder. An alternate method involves testing a sample obtained from the subject for the presence of a polymorphism in the 3' untranslated region of the SLC1A1 gene. The presence of allele C of C/G polymorphism rs3087879 indicates that the patient is susceptible to an anxiety disorder. Furthermore, a method is provided that involves testing a sample obtained from the subject for the presence of a haplotype in the SLC1A1 gene, wherein the combined presence allele G of the A/G polymorphism rs301434 and allele C of C/G polymorphism rs3087879 indicates that the patient is susceptible to a mood disorder.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Slc1a1 marker for anxiety disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Slc1a1 marker for anxiety disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slc1a1 marker for anxiety disorder will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2039179

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.